Your browser doesn't support javascript.
loading
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.
Cristofanilli, Massimo; Pierga, Jean-Yves; Reuben, James; Rademaker, Alfred; Davis, Andrew A; Peeters, Dieter J; Fehm, Tanja; Nolé, Franco; Gisbert-Criado, Rafael; Mavroudis, Dimitrios; Grisanti, Salvatore; Giuliano, Mario; Garcia-Saenz, Jose A; Stebbing, Justin; Caldas, Carlos; Gazzaniga, Paola; Manso, Luis; Zamarchi, Rita; de Lascoiti, Angela Fernandez; De Mattos-Arruda, Leticia; Ignatiadis, Michail; Cabel, Luc; van Laere, Steven J; Meier-Stiegen, Franziska; Sandri, Maria-Teresa; Vidal-Martinez, Jose; Politaki, Eleni; Consoli, Francesca; Generali, Daniele; Cappelletti, Maria Rosa; Diaz-Rubio, Eduardo; Krell, Jonathan; Dawson, Sarah-Jane; Raimondi, Cristina; Rutten, Annemie; Janni, Wolfgang; Munzone, Elisabetta; Carañana, Vicente; Agelaki, Sofia; Almici, Camillo; Dirix, Luc; Solomayer, Erich-Franz; Zorzino, Laura; Darrigues, Lauren; Reis-Filho, Jorge S; Gerratana, Lorenzo; Michiels, Stefan; Bidard, François-Clément; Pantel, Klaus.
Afiliação
  • Cristofanilli M; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: Massimo.Cristofanilli@nm.org.
  • Pierga JY; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.
  • Reuben J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rademaker A; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Davis AA; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Peeters DJ; Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium.
  • Fehm T; Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Nolé F; Division of Medical Senology, European Institute of Oncology, Milan, Italy.
  • Gisbert-Criado R; Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain.
  • Mavroudis D; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece.
  • Grisanti S; Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy.
  • Giuliano M; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
  • Garcia-Saenz JA; DCIBERONC, IdISCC Madrid, Spain.
  • Stebbing J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Caldas C; Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre, University of Cambridge, Cambridge, UK.
  • Gazzaniga P; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Manso L; Hospital 12 de Octubre, Madrid, Spain.
  • Zamarchi R; Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • de Lascoiti AF; Hospital de Navarra, Pamplona, Spain.
  • De Mattos-Arruda L; Val d'Hebron Institute of Oncology, Val d'Hebron University Hospital, and Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Ignatiadis M; Department of Medical Oncology and Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Cabel L; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.
  • van Laere SJ; Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium.
  • Meier-Stiegen F; Department of Gynecology and Obstetrics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Sandri MT; Division of Laboratory Medicine, Humanitas Reseach Hospital, Rozzano, Milan, Italy.
  • Vidal-Martinez J; Clinical Laboratory, Hospital Arnau de Vilanova, Valencia, Spain.
  • Politaki E; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece.
  • Consoli F; Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy.
  • Generali D; Women Cancer Center, Azienda Socio Sanitaria Territoriale di Cremona, University of Trieste, Italy.
  • Cappelletti MR; Women Cancer Center, Azienda Socio Sanitaria Territoriale di Cremona, University of Trieste, Italy.
  • Diaz-Rubio E; DCIBERONC, IdISCC Madrid, Spain.
  • Krell J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Dawson SJ; Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
  • Raimondi C; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Rutten A; Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium.
  • Janni W; Frauenklinik, University of Ulm, Ulm, Germany.
  • Munzone E; Division of Medical Senology, European Institute of Oncology, Milan, Italy.
  • Carañana V; Clinical Oncology, Hospital Arnau de Vilanova, Valencia, Spain.
  • Agelaki S; Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece; Department of Medical Oncology, University Hospital of Heraklion, Greece.
  • Almici C; Department of Transfusion Medicine, Laboratory for Stem Cells Manipulation and Cryopreservation, AO Spedali Civili di Brescia, Brescia, Italy.
  • Dirix L; Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University of Antwerp, Antwerp, Belgium.
  • Solomayer EF; Saarland University, Homburg, Germany.
  • Zorzino L; Division of Laboratory Medicine, Humanitas Reseach Hospital, Rozzano, Milan, Italy.
  • Darrigues L; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.
  • Reis-Filho JS; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Gerratana L; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Medicine, University of Udine, Udine, UD, Italy.
  • Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, INSERM U1018, University Paris-Saclay, University Paris-Sud, Villejuif, France.
  • Bidard FC; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.
  • Pantel K; Department of Tumor Biology, Center of Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Crit Rev Oncol Hematol ; 134: 39-45, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30771872

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Seleção de Pacientes / Células Neoplásicas Circulantes / Estadiamento de Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Seleção de Pacientes / Células Neoplásicas Circulantes / Estadiamento de Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article